<ici-import>
 <journal 	issn="2588-5030"/>
 <issue number="1" volume="17" year="2023" publicationDate="2023-07-01" numberOfArticles="12">
			<article externalId="A-10-313-1">
			<type>ORIGINAL_ARTICLE</type>
			
					<languageVersion language="en">
						<title>Design and Fabrication of Rapid Diagnostic Test Based on Gold Nanosensors to Detect SARS-CoV-2</title>
						<abstract>Abstract

Background and Aims: Early detection of COVID-19 can decrease the motality rate. The diagnostic tools available so far have been based on a) detection of viral genes, b) detection of human antibodies and c) detection of viral antigens, among which detection of viral genes by RT-PCR is recognized as the most reliable method. In order to speed up the detection process and reduce the false negative results presented, it is necessary to design an accurate and fast test.
Methods: A specific probe against N gene was designed and then gold nanoparticles were synthesized by citrate reduction method. The properties of the synthesized Nano systems were determined in terms of size, surface charge, morphology and accuracy of nanoparticle formation using dynamic light scattering device, zeta potential, transmission electron microscope and ultraviolet light spectroscopy. The designed probe was added to gold nanoparticles after activation. Negative and positive samples were taken from patients and added to nanoparticles containing probes.
Results: Due to the free the sulfhydryl group and the high bond energy between the gold and this group, after the probe was added to the nanoparticles, change in color was observed in the nanoparticle solution. UV Spectrum and DLS results showed 4 nm red shift and change in size from 11 to 16 nm, respectively. In the presence of the SARS-CoV-2 RNA, AuNPs-probe would bound with RNA particles, resulting in a space barrier against salt particle on the other hand in negative samples, the salt bridge would be formed and agglomeration of AuNPs and a change in color would be observed by naked eye.</abstract>
						<pdfFileUrl>http://journal.isv.org.ir/article-1-475-en.pdf</pdfFileUrl>
						<publicationDate>2023-06-21</publicationDate>
						<pageFrom>1</pageFrom>
						<pageTo>8</pageTo>
				<keywords>
<keyword>Biosensor</keyword>
<keyword>Colorimetric detection</keyword>
<keyword>Gold Nanoparticles</keyword>
<keyword>Rapid test</keyword>
<keyword>SARS-CoV-2</keyword>
</keywords>
				</languageVersion>
				


	<authors>
	<author>
	<name>Angila</name>
	<surname>Ataei-Pirkooh</surname>
	<email>anjilaataei@gmail.com</email>
	     <order>1</order>
        <instituteAffiliation>Department of virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Omid</name>
	<surname>Pourdakan</surname>
	<email>omid.pourdakan@yahoo.com</email>
	     <order>2</order>
        <instituteAffiliation>Department of Medical Nanotechnology, School of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Ahmad</name>
	<surname>Tavakoli</surname>
	<email>ahmad.tavakoli66@gmail.com</email>
	     <order>3</order>
        <instituteAffiliation>Department of virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Alireza</name>
	<surname>Ghasempour</surname>
	<email>mraagh22@gmail.com</email>
	     <order>4</order>
        <instituteAffiliation>Department of Medical Nanotechnology, School of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Vahid</name>
	<surname>Pirhajati-Mahabadi</surname>
	<email>pirhajati.v@iums.ac.ir</email>
	     <order>5</order>
        <instituteAffiliation>Neuroscience Research Center, Iran University of Medical Sciences, Tehran, Iran</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Alireza</name>
	<surname>Mohebbi</surname>
	     <order>6</order>
        <instituteAffiliation>Department of virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Bita</name>
	<surname>Mehravi</surname>
	<email>mehravibita@gmail.com</email>
	     <order>7</order>
        <instituteAffiliation>Department of Medical Nanotechnology, School of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	</authors>


	</article>



			<article externalId="A-10-352-1">
			<type>ORIGINAL_ARTICLE</type>
			
					<languageVersion language="en">
						<title>Prevalence of Human Coronaviruses NL63, HKU1, 229E, OC43, MERS, and SARS-CoV-2 among Hospitalized Patients with Acute Respiratory Infection in Tehran</title>
						<abstract>Abstract
Background and Aims: Coronaviruses cause upper respiratory ailments and sporadically lower tract sickness in vulnerable populations. This study examined the prevalence of six human coronaviruses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), OC43, 229E, HKU1, NL63, and Middle East respiratory syndrome coronavirus (MERS-CoV) during the 2019 pandemic caused by SARS-CoV-2 in Tehran, Iran.
Material and methods: Specimens were collected from 204 adult patients with acute respiratory illness. The specimens were examined for the presence of six human coronaviruses using consensus and subtype-specific Real-time reverse-transcription polymerase chain reaction (PCR) assays. The demographic and clinical characteristics associated with coronavirus infection were examined retrospectively.
Results: Coronaviruses were identified in 204 adult patients. The gender ratio was 104/100 male and female, respectively. HCoV-229E, HCoV-NL63, HCoV-OC43, HCoV-HKU1, MERS-CoV, and SARS-CoV-2 were detected in 0.5%, 1.0%, 4.0%, 7.4%, 0.0%, and 22.5% of patients, respectively. The acute clinical features were similar across subtypes. There was no report of fatality incidence among the population during the investigation period.
Conclusions: HCoVs could play a significant role in causing upper respiratory tract infections among adults and older children. Based on the findings of this study and those of others, more extensive studies using other diagnostic methods and higher sample sizes are suggested.

&#160;</abstract>
						<pdfFileUrl>http://journal.isv.org.ir/article-1-517-en.pdf</pdfFileUrl>
						<publicationDate>2023-07-01</publicationDate>
						<pageFrom>9</pageFrom>
						<pageTo>14</pageTo>
				<keywords>
<keyword>Human coronavirus</keyword>
<keyword>Pandemic</keyword>
<keyword>Iran</keyword>
<keyword>Prevalence</keyword>
</keywords>
				</languageVersion>
				


	<authors>
	<author>
	<name>Seyed Jalal</name>
	<surname>Kiani</surname>
	<email>kiani.j@iums.ac.ir</email>
	     <order>1</order>
        <instituteAffiliation>Department of Medical Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Atefeh</name>
	<surname>Kachoei Mohaghgh</surname>
	<email>a.mohaghegh91@gmail.com</email>
	     <order>2</order>
        <instituteAffiliation>Department of Medical Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Masoud</name>
	<surname>Eslami</surname>
	<email>eslamimasoud1403@gmail.com</email>
	     <order>3</order>
        <instituteAffiliation>Maham Foundation for Respiration Science (MFRS), Neuroscience Research Centre (NRS), Iran University of Medical Sciences, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Ahmad</name>
	<surname>Tavakoli</surname>
	<email>ahmad.tavakoli66@gmail.com</email>
	     <order>4</order>
        <instituteAffiliation>Research Center of Pediatric Infectious Diseases, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Mohammad Hadi</name>
	<surname>Karbalaie Niya</surname>
	<email>mohamad.karbalai@yahoo.com</email>
	     <order>5</order>
        <instituteAffiliation>Department of Medical Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Alireza</name>
	<surname>Javan</surname>
	<email>alirezajavan1365@gmail.com</email>
	     <order>6</order>
        <instituteAffiliation>Student Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Sheyda</name>
	<surname>Alizadeh</surname>
	<email>alizadehsheyda1402@gmail.com</email>
	     <order>7</order>
        <instituteAffiliation>Department of Bacteriology and Virology, Shiraz University of Medical Science, Shiraz, Iran</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>zahra</name>
	<surname>salavatiha</surname>
	<email>z.salavatiha96@gmail.com</email>
	     <order>8</order>
        <instituteAffiliation>Department of Medical Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Mahdieh</name>
	<surname>Hosseini</surname>
	<email>hoseini6694@yahoo.com</email>
	     <order>9</order>
        <instituteAffiliation>Department of Medical Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>zahra</name>
	<surname>Safaei</surname>
	<email>zahra.safaie@hotmail.com</email>
	     <order>10</order>
        <instituteAffiliation>Department of Medical Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Mohamadreza</name>
	<surname>Rezvani</surname>
	<email>mohamadrezarezvani574@gmail.com</email>
	     <order>11</order>
        <instituteAffiliation>Department of Hematology and Blood Transfusion, School of Allied Medical Sciences, Iran University of Medical Sciences, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Seyed Hamidreza</name>
	<surname>Monavari</surname>
	<email>Monavari.hr@iums.ac.ir</email>
	     <order>12</order>
        <instituteAffiliation>Department of Medical Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	</authors>


	</article>



			<article externalId="A-10-270-4">
			<type>ORIGINAL_ARTICLE</type>
			
					<languageVersion language="en">
						<title>Detection of Respiratory Viruses in Children Less than 5 Years of Age with Suspected COVID-19 Infection in East Azerbaijan Iran</title>
						<abstract>Abstract
Background and Aims: Coronaviruses are one of the most common viral agents associated with respiratory disease in children, causing severe respiratory infections and hospitalizations in children. However, there is no information about the prevalence of these seasonal coronavirus infection in the northwest of Iran. The aim of this study was to identify and investigate the frequency of NL63, OC-43 and 229E, Influenza type A, B viruses in children less than 5 years of age with respiratory infection in the northwest of Iran during the COVID-19 pandemic.
Material&#38; Method: In the present study, 164 respiratory samples were taken from children with respiratory problems who were negative for influenza type A, B and SARS-CoV-2 (Taqman Real Time RT-PCR method). NL63, OC-43 and 229E viruses were evaluated in a panel by Cyber green RT-PCR method.
Results: In our investigation, 2 out of 164 (1.2%) cases of NL63 infection were detected in children less than one year, but OC-43 and 229E viruses were not detected.&#160; NL63 positive samples in this study were detected in late winter and early spring.
Conclusion: Considering the role of this virus in causing respiratory problems in children and immunocompromised patients, identification and diagnosis of these pathogens in respiratory samples is important. Paying attention to viral infections in the northwest of Iran can play an important role in improving the management of infectious agents in this area.

&#160;</abstract>
						<pdfFileUrl>http://journal.isv.org.ir/article-1-496-en.pdf</pdfFileUrl>
						<publicationDate>2023-07-10</publicationDate>
						<pageFrom>15</pageFrom>
						<pageTo>25</pageTo>
				<keywords>
<keyword>Coronaviruses</keyword>
<keyword>SARS-CoV-2</keyword>
<keyword>HCoV-NL-63</keyword>
<keyword>HCoV-OC-43</keyword>
<keyword>HCoV-229E</keyword>
<keyword>Acute Respiratory Tract Infections (ARTI)</keyword>
</keywords>
				</languageVersion>
				


	<authors>
	<author>
	<name>Moslem</name>
	<surname>Ghaseminia</surname>
	<email>moslemghaseminia7386@gmail.com</email>
	     <order>1</order>
        <instituteAffiliation>Department of Microbiology &#38; Virology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Vahdat</name>
	<surname>Poortahmasebi</surname>
	<email>vahdat2011@gmail.com</email>
	     <order>2</order>
        <instituteAffiliation>Department of Microbiology &#38; Virology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Arezou</name>
	<surname>Azadi</surname>
	<email>azadi_arezou@yahoo.com</email>
	     <order>3</order>
        <instituteAffiliation>Department of Microbiology &#38; Virology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Hossein</name>
	<surname>Bannazadeh Baghi</surname>
	<email>hbannazadeh@tbzmed.ac.ir</email>
	     <order>4</order>
        <instituteAffiliation>Infectious and Tropical Diseases Research Center,&#59; Department of Microbiology &#38; Virology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Mahin</name>
	<surname>Ahangar Oskouee</surname>
	<email>ahangar1342@gmail.com</email>
	     <order>5</order>
        <instituteAffiliation>Infectious and Tropical Diseases Research Center,&#59; Department of Microbiology &#38; Virology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran</instituteAffiliation>  
	    <role>AUTHOR</role>
	<ORCID>https://orcid.org/0000-0002-9682-8835</ORCID>
	 </author>
	</authors>


	</article>



			<article externalId="A-10-355-1">
			<type>ORIGINAL_ARTICLE</type>
			
					<languageVersion language="en">
						<title>Clinical Findings and Mortality Rate of Patients with Multiple Myeloma Following COVID-19 infection: Report from Iranian Network for Research in Viral Diseases (INRVD)</title>
						<abstract>Abstract
Background and Aims: COVID-19 is a viral disease that spreads easily, caused by the SARS-CoV-2 virus. This illness has led to a worldwide pandemic and has caused many human fatalities. Patients with cancer have a weakened immune system, which makes them more susceptible to various infections. In this research, we wanted to compare mortality, hospitalization rate, and clinical findings in multiple myeloma (MM) patients.
Materials and Methods: This research examined the effect of COVID-19 on sixteen individuals diagnosed with MM. Four hospitals&#8212;Imam Khomeini, Rouhani, Shariati, and Sina&#8212;were included in the study. All participants in affiliated hospitals underwent Real-time PCR testing to determine whether they had a viral infection with SARS-CoV-2. According to Iranian CDC guidelines, the real-time reverse transcription-polymerase chain reaction (RT-PCR) test was performed on throat specimens using flocked swabs obtained immediately upon admission to confirm SARS-CoV-2 infection. Collaborative clinical virology necessitates the utilization of two pairs of primers, each designed to target two specific genes (the E gene and the RdRP gene).
Results: Patients with MM were found to have a considerably higher risk of hospitalization and mortality from COVID-19, as per the study results. Common symptoms observed in MM patients with COVID-19 included fever (87.5%), cough (87.5%), and dyspnea (62.5%). Moreover, the study revealed a substantial 17-fold increase in the odds of MM patients with COVID-19 positive compared to their counterparts without COVID-19.
Conclusion: The study results emphasize the critical significance of prompt identification of COVID-19 among patients with MM. It underscores the importance of implementing public health measures, vaccination efforts, and continued research to effectively prevent severe illness and fatalities related to COVID-19 within this vulnerable population.</abstract>
						<pdfFileUrl>http://journal.isv.org.ir/article-1-520-en.pdf</pdfFileUrl>
						<publicationDate>2023-06-11</publicationDate>
						<pageFrom>26</pageFrom>
						<pageTo>33</pageTo>
				<keywords>
<keyword>Multiple Myeloma</keyword>
<keyword>COVID-19</keyword>
<keyword>SARS-CoV-2</keyword>
<keyword>Respiratory Infection</keyword>
<keyword>cancer</keyword>
</keywords>
				</languageVersion>
				


	<authors>
	<author>
	<name>Zahra</name>
	<surname>Ghandehari</surname>
	<email>ghandeharizahra1@gmail.com</email>
	     <order>1</order>
        <instituteAffiliation>Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Omid</name>
	<surname>Salahi Ardekani</surname>
	<email>omid.salahi23@gmail.com</email>
	     <order>2</order>
        <instituteAffiliation>Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Behnaz</name>
	<surname>Hammami</surname>
	<email>Behnaz.hamami1994@gmail.com</email>
	     <order>3</order>
        <instituteAffiliation>Department of genetics and molecular biology, school of medicine, Isfahan University of Medical Sciences, Isfahan, Iran</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Mahya</name>
	<surname>Arabi</surname>
	<email>arabiimahya@gmail.com</email>
	     <order>4</order>
        <instituteAffiliation>Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Morteza</name>
	<surname>Rajabi</surname>
	<email>morteza.rajabi7575@gmail.com</email>
	     <order>5</order>
        <instituteAffiliation>Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Sara</name>
	<surname>Shivaei</surname>
	<email>sarashivaeii@gmail.com</email>
	     <order>6</order>
        <instituteAffiliation>Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Alireza</name>
	<surname>Etrati Kooshali</surname>
	<email>alireza.etrati@gmail.com</email>
	     <order>7</order>
        <instituteAffiliation>Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Melina</name>
	<surname>Molaeian</surname>
	<email>melina808050@gmail.com</email>
	     <order>8</order>
        <instituteAffiliation>Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Mohammad Mehdi</name>
	<surname>Fazeli</surname>
	<email>Mohammadmehdifazeli80@gmail.com</email>
	     <order>9</order>
        <instituteAffiliation>Department of Virology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Fateme</name>
	<surname>Nurzad</surname>
	<email>Fatemehnoorzad77@gmail.com</email>
	     <order>10</order>
        <instituteAffiliation>Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Arash</name>
	<surname>Letafati</surname>
	<email>arashletafati@yahoo.com</email>
	     <order>11</order>
        <instituteAffiliation>Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Mohammad Mahdi</name>
	<surname>Behzadifar</surname>
	<email>m.mahdibehzadifar81@gmail.com</email>
	     <order>12</order>
        <instituteAffiliation>Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Sheida</name>
	<surname>Sarrafzadeh</surname>
	<email>shsarafzadeh@gmail.com</email>
	     <order>13</order>
        <instituteAffiliation>Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Mehdi</name>
	<surname>Norouzi</surname>
	<email>mnorouzi@tums.ac.ir</email>
	     <order>14</order>
        <instituteAffiliation>Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	</authors>


	</article>



			<article externalId="A-10-355-2">
			<type>ORIGINAL_ARTICLE</type>
			
					<languageVersion language="en">
						<title>Surviving the Double Threat: A Holistic Study on Clinical Manifestations of SARS-CoV-2 and Mortality among Patients with Cancer</title>
						<abstract>Abstract
Background and Aims: The appearance of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) gave rise to the global coronavirus disease 2019 (COVID-19) pandemic. SARS-CoV-2 primarily affects the respiratory system, ranging from mild to severe symptoms. Cancer patients are at higher risk of severe outcomes and mortality rates due to compromised immune systems.This study aims to evaluate the clinical findings of cancer patients following infection with SARS-CoV-2, emphasizing the need for tailored approaches to address challenges during the COVID-19 pandemic.
Methods: The study enrolled a total of 158 individuals, all of whom had previously been diagnosed with various cancers and tested positive for SARS-CoV-2 with Real-time PCR. Demographic information of patients, characteristics of underlying diseases, type of cancer and clinical symptoms with geographical distribution of Iranian provinces by the Iran Viral Research Network were investigated.
Results: Among 158 patients, 62.65% were male and 37.34% were female. The majority were over 60 years old (55.69%). Leukemia was the predominant cancer (37.34%), followed by genital cancers and breast cancer (each at 13.51%). Respiratory symptoms were prominent, with shortness of breath (59.49%) and dry cough (41.77%) being the most common. Other symptoms such as runny nose (6.32%), sore throat (6.96%), and lethargy (41.77%) were common. Digestive symptoms like anorexia (25.31%) and nausea (10.75%) were also observed in a significant percentage of patients. In total, nine (5.6%) patients passed away during the study.
Conclusion: In conclusion, this study provides insights into the clinical manifestations of SARS-CoV-2 infection in cancer patients, revealing a higher susceptibility to severe outcomes due to compromised immune systems. The majority of patients exhibited respiratory symptoms, with leukemia being the most prevalent cancer type. These findings underscore the importance of tailored approaches in managing COVID-19 in cancer patients. As the pandemic continues, it is imperative to implement strategies that mitigate the risk and optimize care for this vulnerable population.</abstract>
						<pdfFileUrl>http://journal.isv.org.ir/article-1-524-en.pdf</pdfFileUrl>
						<publicationDate>2023-06-21</publicationDate>
						<pageFrom>34</pageFrom>
						<pageTo>41</pageTo>
				<keywords>
<keyword>Cancer</keyword>
<keyword>SARS-CoV-2</keyword>
<keyword>COVID-19</keyword>
<keyword>Pandemic</keyword>
<keyword>Clinical symptoms</keyword>
</keywords>
				</languageVersion>
				


	<authors>
	<author>
	<name>Mehdi</name>
	<surname>Norouzi</surname>
	<email>mnorouzi@tums.ac.ir</email>
	     <order>1</order>
        <instituteAffiliation>Research Center for Clinical Virology, Tehran University of Medical Science, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Omid</name>
	<surname>Salahi Ardekani</surname>
	<email>omid.salahi23@gmail.com</email>
	     <order>2</order>
        <instituteAffiliation>Research Center for Clinical Virology, Tehran University of Medical Science, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Mohammad Reza</name>
	<surname>Mohammadi</surname>
	<email>mreza_mohammadi@modares.ac.ir</email>
	     <order>3</order>
        <instituteAffiliation>Department of Bacteriology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Erfan</name>
	<surname>Kordi</surname>
	<email>erfan.kordi2004@gmail.com</email>
	     <order>4</order>
        <instituteAffiliation>Research Center for Clinical Virology, Tehran University of Medical Science, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Roxana</name>
	<surname>Tajdini</surname>
	<email>roxanatajdini37@gmail.com</email>
	     <order>5</order>
        <instituteAffiliation>Research Center for Clinical Virology, Tehran University of Medical Science, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Zahra</name>
	<surname>Aboughadareh Nasab</surname>
	<email>Aboughadarehza@gmail.com</email>
	     <order>6</order>
        <instituteAffiliation>Research Center for Clinical Virology, Tehran University of Medical Science, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Parsa</name>
	<surname>Ghafari</surname>
	<email>parsaghf85@gmail.com</email>
	     <order>7</order>
        <instituteAffiliation>Iranian Network for Research in Viral Diseases (INRVD).</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Mahya</name>
	<surname>Arabi</surname>
	<email>arabiimahya@gmail.com</email>
	     <order>8</order>
        <instituteAffiliation>Research Center for Clinical Virology, Tehran University of Medical Science, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Mohammad Sina</name>
	<surname>Khanbabazade</surname>
	<email>Khanbabazadehsina@gmail.com</email>
	     <order>9</order>
        <instituteAffiliation>Research Center for Clinical Virology, Tehran University of Medical Science, Tehran, Iran</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Mina</name>
	<surname>Naderisemiromi</surname>
	<email>minanaderi767@yahoo.com</email>
	     <order>10</order>
        <instituteAffiliation>Department of Infectious Immunology, Manchester University, Manchester, UK.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	</authors>


	</article>



			<article externalId="A-10-124-2">
			<type>ORIGINAL_ARTICLE</type>
			
					<languageVersion language="en">
						<title>Research Trends on Human Papilloma Virus In Iran: A Scientometric Analysis Based on ISI Web of Science (WoS) Data</title>
						<abstract>Abstract
Background and Aims: Human papillomaviruses are the most common sexually transmitted infections, with high-risk types linked to cervical cancer in women and other cancers in both sexes. Analyzing published data can guide future research priorities and address overlooked areas. Bibliometric analysis, which assesses research activities in a specific field, is a valuable tool for this purpose. To understand HPV research trends in Iran, a scientometric analysis was conducted on articles published by Iranian researchers in the HPV field from 2002 to 2023 and indexed in the Web of Science database. 74% of the articles were original, with the highest publication rate in 2021. Tehran University of Medical Sciences had the most publications. Cancer-related studies received the most attention, while genital warts research was less common. Gene cloning/protein expression, adjuvants/nano-delivery systems and therapeutic vaccines was found to be the most popular area of studies on HPV vaccine. The number of publications in Iran is significantly lower compared to developed countries. It is imperative to delve deeper into various aspects of HPV within the country. Enhancing the quality of original studies that delve into the basic aspects of HPV is crucial. Research on HPV vaccines should be structured as extensive, collaborative endeavors involving universities and vaccine manufacturers. Further investigations into genital warts are warranted.</abstract>
						<pdfFileUrl>http://journal.isv.org.ir/article-1-518-en.pdf</pdfFileUrl>
						<publicationDate>2023-07-01</publicationDate>
						<pageFrom>42</pageFrom>
						<pageTo>47</pageTo>
				<keywords>
<keyword>Human papillomavirus</keyword>
<keyword>Web of Science</keyword>
<keyword>Scientometric analysis</keyword>
<keyword>Iran.</keyword>
</keywords>
				</languageVersion>
				


	<authors>
	<author>
	<name>Ahmad</name>
	<surname>Yousefi</surname>
	<email>a.yousefi@rvsri.ac.ir</email>
	     <order>1</order>
        <instituteAffiliation>Library and Scientific Documentation Center, Razi Vaccine &#38; Serum Research Institute, Agricultural Research Education and Extension Organization (AREEO), Karaj, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Mohammad Kazem</name>
	<surname>Shahkarami</surname>
	<email>k.shahkarami@rvsri.ac.ir</email>
	     <order>2</order>
        <instituteAffiliation>Human Viral Vaccines Department, Razi Vaccine &#38; Serum Research Institute, Agricultural Research Education and Extension Organization (AREEO), Karaj, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	</authors>


	</article>



			<article externalId="A-10-1-107">
			<type>ORIGINAL_ARTICLE</type>
			
					<languageVersion language="en">
						<title>Study of Fibroblast Growth Factor 3 (fgf-3) Gene Expression in Breast Cancer Tissues Infected with Mouse Mammary Tumor Virus (MMTV)</title>
						<abstract>Abstract
Background and Aims: Breast cancer (BC) is the second most common cancer among women worldwide. Several factors can influence the occurrence of BC, including the presence of murine mammary tumor virus (MMTV). In this study, we aimed to perform the epidemiology of MMTV and investigation of human fgf-3 gene expression in cancerous and noncancerous individuals infected with MMTV
Materials and Methods: A total of 85 BC tissue samples and 85 tumor-free margin tissue samples (normal tissue) were collected from women undergoing breast surgery at general hospitals in the Qom Province, Iran. The presence of the MMTV env gene was determined using the nested PCR method. Additionally, the correlation between the fgf-3 gene expression and the MMTV-env gene conducted by Real-time PCR for the first time in Iran.
Results: The MMTV env gene was detected in 16 (18.8%) out of 85 BC tissue samples, but in only 2 (2.35%) samples without cancer. In the MMTV-positive samples, the expression of the fgf-3 gene was increased compared to MMTV-negative samples (P=0.012). Furthermore, there was no significant difference in fgf-3 gene expression between grade I and II BC samples. However, a significant increase in fgf-3 gene expression was observed in grade III and TNBC cases. (P&#60; 0.05).
Conclusion: The mouse mammary tumor virus represents a significant risk factor for BC. Therefore, implementing preventive measures, including timely MMTV infection detection and control, can be effective in BC prevention programs in Iran and globally.</abstract>
						<pdfFileUrl>http://journal.isv.org.ir/article-1-540-en.pdf</pdfFileUrl>
						<publicationDate>2023-07-10</publicationDate>
						<pageFrom>48</pageFrom>
						<pageTo>56</pageTo>
				<keywords>
<keyword>MMTV</keyword>
<keyword>Breast cancer</keyword>
<keyword>fgf-3 gene</keyword>
<keyword>Real-time PCR method.</keyword>
</keywords>
				</languageVersion>
				


	<authors>
	<author>
	<name>Hassan</name>
	<surname>Vahidi Emami</surname>
	     <order>1</order>
        <instituteAffiliation>Department of Microbiology and Immunology, School of the Veterinary Medicine, University of Tehran, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Arash</name>
	<surname>Ghalyanchi Langeroudi</surname>
	<email>ghalyana@ut.ac.ir</email>
	     <order>2</order>
        <instituteAffiliation>Department of Microbiology and Immunology, School of the Veterinary Medicine, University of Tehran, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Seyed Masoud</name>
	<surname>Hosseini</surname>
	     <order>3</order>
        <instituteAffiliation>Department of Microbiology and Microbial Biotechnology, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Hamideh</name>
	<surname>Najafi</surname>
	     <order>4</order>
        <instituteAffiliation>Department of Microbiology and Immunology, School of the Veterinary Medicine, University of Tehran, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	</authors>


	</article>



			<article externalId="A-10-339-1">
			<type>ORIGINAL_ARTICLE</type>
			
					<languageVersion language="en">
						<title>Investigation of the Relationship between Virus Neutralization Test and ELISA with Challenge Test in Evaluation of FMD Vaccine Potency</title>
						<abstract>Abstract
Background and Aims: Foot-and-mouth disease (FMD), is a highly infectious and contagious disease in livestock. An effective and efficient vaccine is needed to Control FMD and reduces the associated damage. The goal of this study was to find out if the protective dose or challenge (PD50%) could be used instead of the antibody titer method to measure the effectiveness of the FMD vaccine. To achieve this, several calves were selected and divided into four groups. The vaccine was administered in three doses: a full dose, a 1/3 dose and a 1/9 dose. Twenty-one days after vaccination, all animals were challenged with a 10,000 LID50% virus in the tongue epithelium. For 7 days after, the animals were evaluated and monitored for the appearance of FMD symptoms. The PD50% (Protective Dose) for each vaccine against the virus was determined in the experiment. After obtaining the VN results that indicated the antibody titer and the PD50% level, a comparison was made between these two parameters. By examining 5 test cases, a formula was derived that accurately determined the PD50% with a high degree of precision using the VN50% result. This study determined the constants for A and O types using the VN50% test results. By incorporating these values into the derived formula, the PD50% level could be determined.</abstract>
						<pdfFileUrl>http://journal.isv.org.ir/article-1-507-en.pdf</pdfFileUrl>
						<publicationDate>2023-07-19</publicationDate>
						<pageFrom>57</pageFrom>
						<pageTo>62</pageTo>
				<keywords>
<keyword>FMD</keyword>
<keyword>serum neutralization test</keyword>
<keyword>inactivated FMD vaccine</keyword>
<keyword>challenge test</keyword>
<keyword>determination of protective dose.</keyword>
</keywords>
				</languageVersion>
				


	<authors>
	<author>
	<name>Mahdieh</name>
	<surname>Akbarzadegan</surname>
	<email>mh.akbarzadegan@yahoo.com</email>
	     <order>1</order>
        <instituteAffiliation>Department of Biology, Faculty of Sciences, Central Tehran Branch, Islamic Azad University, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Homayoon</name>
	<surname>Mahravani</surname>
	<email>mahravani2010@gmail.com</email>
	     <order>2</order>
        <instituteAffiliation>Foot and Mouth Disease Reference Laboratory, Razi Vaccine &#38; Serum Research Institute, Agricultural Research Education and Extension Organization (AREEO), Karaj, Iran.                                       institute. Agricultural Research Education and Extension Organization (AREEO),                    Karaj,  Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	<ORCID>https://orcid.org/0000-0002-9802-2034</ORCID>
	 </author>
	<author>
	<name>Zeinab</name>
	<surname>Piravar</surname>
	<email>saba.piravar@gmail.com</email>
	     <order>3</order>
        <instituteAffiliation>Department of Biology, Faculty of Sciences, Central Tehran Branch, Islamic Azad University, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	<ORCID>https://orcid.org/0000-0001-8949-362X</ORCID>
	 </author>
	</authors>


	</article>



			<article externalId="A-10-348-1">
			<type>ORIGINAL_ARTICLE</type>
			
					<languageVersion language="en">
						<title>Molecular Epidemiology of Caprine Arthritis Encephalitis Virus (CAEV) in Imported and Indigenous Dairy Goat Breeds in Iran</title>
						<abstract>Abstract
Background and Aims: Virus of caprine arthritis encephalitis belongs to the Retrovirdae family, which can cause arthritis, mastitis and abortion in adult goats, and encephalitis in kids especially in dairy breeds. Therfore, income of farmers are affected .since, in the recent years many importation of small ruminant animals especially dairy goats breeds to our country have been done . This study was conducted to evaluate infection of CAEV in imported and indigenous dairy goat breeds which were kept together in one herd.
Materials and methods: In this study, blood samples were taken from 249 dairy goats in one of the industrial breeding farm. Buffy coat was separated from the samples using centrifugation and DNA was extracted from them. Nested polymerase chain reaction (Nested PCR) method was performed with specific primers in order to detect the gag gene.
Results: The gag gene was detected in21 blood samples (8.3%) out of 249&#160; samples and result of CAEV&#160; Infection rate was 11 (13.8%), 7 (8.1%) and 3 (3.6%) for Alpine, Saanen and Indigenous breeds, respectively. Percent of infection based on old was 15.8%, in &#60; two years goats, 8% in 2 3 years and 7.7% &#62; three years old.
Conclusion: Unfortunately, the imported and local breed of dairy goats were infected with CAEV, therefore, phylogeny studies are required to for identification of prevalence of the disease in herds of the country.</abstract>
						<pdfFileUrl>http://journal.isv.org.ir/article-1-513-en.pdf</pdfFileUrl>
						<publicationDate>2023-07-28</publicationDate>
						<pageFrom>63</pageFrom>
						<pageTo>69</pageTo>
				<keywords>
<keyword>Caprine arthritis encephalitis</keyword>
<keyword>CAEV</keyword>
<keyword>Nested PCR</keyword>
<keyword>gag</keyword>
<keyword>Iran</keyword>
</keywords>
				</languageVersion>
				


	<authors>
	<author>
	<name>Fereydoun</name>
	<surname>Mansouri</surname>
	<email>manesht_1100@yahoo.com</email>
	     <order>1</order>
        <instituteAffiliation>Department of Microbiology and Immunology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Bahman</name>
	<surname>Abedi kiasari</surname>
	<email>abedikiasari.b@ut.ac.ir</email>
	     <order>2</order>
        <instituteAffiliation>Department of Microbiology and Immunology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Mahdi</name>
	<surname>Vejgani</surname>
	<email>vodjgani@ut.ac.ir</email>
	     <order>3</order>
        <instituteAffiliation>Department of Theriogenology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Mohammad Mehdi</name>
	<surname>Ranjbar</surname>
	<email>mm.ranjbar.phd@gmail.com</email>
	     <order>4</order>
        <instituteAffiliation>Razi Vaccine and Serum Research Institute, Agricultural Research, Education, and Extension Organization (AREEO), Karaj, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Shahab</name>
	<surname>Falahi</surname>
	<email>Shahabivan@gmail.com</email>
	     <order>5</order>
        <instituteAffiliation>Zoonotic Diseases Research Center, Ilam University of Medical Sciences, Ilam, Iran</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	</authors>


	</article>



			<article externalId="A-10-1-108">
			<type>ORIGINAL_ARTICLE</type>
			
					<languageVersion language="en">
						<title>Immunosuppression Viral Diseases in Healthy Broiler Flocks: The Pilot Study</title>
						<abstract>Abstract
Background and Aims: Immunosuppressive viral diseases have become a significant reason for mor-tality and economic losses in the poultry industry, mainly because of the increased susceptibility of to second bacterial infections and low responses to vaccination. The aim of this study, was to investigate the immunosuppressive viral agent, including IBDV, IBV, MDV, FadV, NDV, AIV, and CAV, in healthy farms. Bursas samples were collected from 3-4 week old broilers farm without clinical signs. One part of bursas fixed by immersion in 10% buffered formalin for histopathologic study and other parts selected for molecular studies. The RNA and DNA were extracted. PCR and RT-PCR were performed for this RNA and DNA viruses, respectively, and Phylogenetic analysis was conducted for IBD positive samples, also fixed tissue prepared for the histopathological purpose. Generally, four samples of 12 bursas samples were IBDV positive, five samples IBV positive (%41.66), and two samples MDV positive (16.66%).
Interestingly these four IBDV positive samples showed the histopathological changes described above. According to the results of PCR and histopathology determine that % 33.33 of broilers farm in Iran are suffering from subclinical IBD. All samples for AIV, NDV, CAV, and IBH were negative in PCR detection methods. The phylogenic tree analysis results show that these sequences are similar to other IBDV strains circulating in Iran broiler farms and belong to very virulent IBDV genogroups.</abstract>
						<pdfFileUrl>http://journal.isv.org.ir/article-1-541-en.pdf</pdfFileUrl>
						<publicationDate>2023-07-06</publicationDate>
						<pageFrom>70</pageFrom>
						<pageTo>75</pageTo>
				<keywords>
<keyword>Immunosuppression</keyword>
<keyword>Infectious bursal disease</keyword>
<keyword>Histopathology</keyword>
<keyword>PCR</keyword>
<keyword>Bursa of Fabricius</keyword>
</keywords>
				</languageVersion>
				


	<authors>
	<author>
	<name>Arash</name>
	<surname>Ghalyanchi-Langeroudi</surname>
	     <order>1</order>
        <instituteAffiliation>Department of Microbiology and Immunology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Seyed Ahmad</name>
	<surname>Madani</surname>
	     <order>2</order>
        <instituteAffiliation>Department of Animal and Poultry Health and Nutrition, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Naser</name>
	<surname>Sadri</surname>
	     <order>3</order>
        <instituteAffiliation>Department of Microbiology and Immunology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Zahra</name>
	<surname>Ziafatikafi</surname>
	     <order>4</order>
        <instituteAffiliation>Department of Microbiology and Immunology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Soroush</name>
	<surname>Sarmadi</surname>
	     <order>5</order>
        <instituteAffiliation>Department of Microbiology and Immunology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>fahimeh</name>
	<surname>Jamiri</surname>
	     <order>6</order>
        <instituteAffiliation>Department of Microbiology and Immunology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Alireza</name>
	<surname>Bakhshi</surname>
	     <order>7</order>
        <instituteAffiliation>Department of Microbiology and Immunology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Omid</name>
	<surname>Eghbali</surname>
	     <order>8</order>
        <instituteAffiliation>Department of Microbiology and Immunology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Hossein</name>
	<surname>Hosseini</surname>
	<email>hosseini.ho@gmail.com</email>
	     <order>9</order>
        <instituteAffiliation>Department of Clinical Sciences, Faculty of Veterinary Medicine, Karaj Branch, Islamic Azad University, Alborz, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	</authors>


	</article>



			<article externalId="A-10-354-1">
			<type>CASE_STUDY</type>
			
					<languageVersion language="en">
						<title>Treating of A Patient Infected with COVID-19 Virus by Newcastle Disease Virus</title>
						<abstract>&#160;No abstract</abstract>
						<pdfFileUrl>http://journal.isv.org.ir/article-1-519-en.pdf</pdfFileUrl>
						<publicationDate>2023-07-15</publicationDate>
						<pageFrom>76</pageFrom>
						<pageTo>77</pageTo>
				<keywords>
<keyword>Newcastle virus</keyword>
<keyword>interference</keyword>
<keyword>covid-19</keyword>
<keyword>treatment case report</keyword>
</keywords>
				</languageVersion>
				


	<authors>
	<author>
	<name>Masoud</name>
	<surname>Moghaddam pour</surname>
	<email>m.moghaddam@rvsri.ac.ir</email>
	     <order>1</order>
        <instituteAffiliation>Razi Vaccine and Serum Research Institute (Hesarak), Agricultural Research, Education and Extension Organiza-tion (AREEO), Tehran, Iran.</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	</authors>


	</article>



			<article externalId="A-10-333-1">
			<type>REVIEW_ARTICLE</type>
			
					<languageVersion language="en">
						<title>Monkeypox Poses A Serious Public Health Challenge, A Comprehensive Review</title>
						<abstract>Abstract
Background and Aims: Monkeypox (MPX) is a zoonotic disease due to Orthopoxvirus infection that has reemerged after decades of Smallpox eradication, raising international concern. Monkeypox virus (MPXV) was originally found in Central and West Africa in the 1970s, but it has now crossed the borders of Africa, Europe, and America and recorded the most newly infected patients at the time. Common ways of transmission could be the zoonotic and human-to-human transmission. The most common means of transmission are direct and prolonged contact with patient bodily fluids, unprotected contact with lesions, and sexual contact. Early symptoms can manifest as headache, fever, and lymph node inflammation. Despite the similarity in clinical manifestation between Smallpox and Monkeypox, swollen lymph nodes can distinguish MPX from Smallpox. MPX has five stages based on the clinical manifestation of lesions appearing on the skin, macula, papule, vesicle, pustule, and scar. Also, there are several methods for detecting, preventing, and treating MPXV. This paper provides a comprehensive review of Monkeypox and various aspects of the disease were discussed.


&#160;</abstract>
						<pdfFileUrl>http://journal.isv.org.ir/article-1-500-en.pdf</pdfFileUrl>
						<publicationDate>2023-07-24</publicationDate>
						<pageFrom>78</pageFrom>
						<pageTo>91</pageTo>
				<keywords>
<keyword>Monkeypox</keyword>
<keyword>Poxviruses</keyword>
<keyword>Diagnosis</keyword>
<keyword>Transmission</keyword>
<keyword>Phylogeny</keyword>
<keyword>Epidemiology</keyword>
</keywords>
				</languageVersion>
				


	<authors>
	<author>
	<name>Mohammad Jalil</name>
	<surname>Zorriehzahra</surname>
	<email>zorrieh@yahoo.com</email>
	     <order>1</order>
        <instituteAffiliation>Department of Scientific Information and Communication, Iranian Fisheries Science Research Institute (IFSRI), Agricultural Research Education and Extension Organization (AREEO), Tehran, I.R. Iran</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Sana</name>
	<surname>Yousefian Jazi</surname>
	<email>sanayousefian@yahoo.com</email>
	     <order>2</order>
        <instituteAffiliation>Department of Cell and Molecular Biology and Microbiology, Faculty of Biological Science and Technology, University of Isfahan, Isfahan, I.R. Iran</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Fariba</name>
	<surname>Ghaed Amini</surname>
	<email>faribaamini98@gmail.com</email>
	     <order>3</order>
        <instituteAffiliation>Department of Management and Health Information Technology, School of Management and Medical Information Sciences, Isfahan University of Medical Sciences, Isfahan, IR. Iran</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	<author>
	<name>Parisa</name>
	<surname>Mohammadisefat</surname>
	<email>parisamohammadisefat@yahoo.com</email>
	     <order>4</order>
        <instituteAffiliation>Department of Fisheries Science, Urmia University, Urmia, I.R. Iran</instituteAffiliation>  
	    <role>AUTHOR</role>
	 </author>
	</authors>


	</article>


	</issue>
 </ici-import>
 
  
  
  
  
 